Synlogic, Inc. (NASDAQ: SYBX) is a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology.
| Headquarters | Cambridge, MA |
| Website | www.synlogictx.com |
| @synlogic_tx | |
| Pipeline | Phase 2 clinical trials |
| Partners | AbbVie |